Clement Agoni

1.2k total citations
74 papers, 924 citations indexed

About

Clement Agoni is a scholar working on Molecular Biology, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Clement Agoni has authored 74 papers receiving a total of 924 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 23 papers in Computational Theory and Mathematics and 11 papers in Infectious Diseases. Recurrent topics in Clement Agoni's work include Computational Drug Discovery Methods (23 papers), RNA and protein synthesis mechanisms (8 papers) and ATP Synthase and ATPases Research (8 papers). Clement Agoni is often cited by papers focused on Computational Drug Discovery Methods (23 papers), RNA and protein synthesis mechanisms (8 papers) and ATP Synthase and ATPases Research (8 papers). Clement Agoni collaborates with scholars based in South Africa, Ghana and Ireland. Clement Agoni's co-authors include Mahmoud E. S. Soliman, Fisayo A. Olotu, Pritika Ramharack, Abdul Rashid Issahaku, Opeyemi Soremekun, Mithun Rudrapal, Deepak K. Lokwani, Atul R. Bendale, Sami G. Almalki and Johra Khan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Scientific Reports.

In The Last Decade

Clement Agoni

74 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clement Agoni South Africa 18 471 229 155 96 92 74 924
Fisayo A. Olotu South Africa 18 439 0.9× 162 0.7× 160 1.0× 144 1.5× 103 1.1× 79 857
Ramakrishna Vadde India 19 430 0.9× 191 0.8× 105 0.7× 173 1.8× 47 0.5× 52 1.1k
Thales Kronenberger Germany 16 421 0.9× 244 1.1× 152 1.0× 103 1.1× 61 0.7× 92 877
Bilal Shaker South Korea 12 426 0.9× 276 1.2× 99 0.6× 60 0.6× 55 0.6× 21 771
Shailima Rampogu South Korea 20 524 1.1× 334 1.5× 256 1.7× 52 0.5× 69 0.8× 60 1.0k
Umashankar Vetrivel India 22 718 1.5× 164 0.7× 87 0.6× 93 1.0× 81 0.9× 115 1.3k
Stephani Joy Y. Macalino Philippines 12 595 1.3× 425 1.9× 153 1.0× 110 1.1× 46 0.5× 19 942
Katrin Stierand Germany 10 677 1.4× 304 1.3× 230 1.5× 71 0.7× 44 0.5× 15 1.2k
Prem Prakash Kushwaha India 19 453 1.0× 200 0.9× 108 0.7× 155 1.6× 49 0.5× 43 983
Shama Khan South Africa 17 389 0.8× 176 0.8× 98 0.6× 86 0.9× 38 0.4× 44 705

Countries citing papers authored by Clement Agoni

Since Specialization
Citations

This map shows the geographic impact of Clement Agoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clement Agoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clement Agoni more than expected).

Fields of papers citing papers by Clement Agoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clement Agoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clement Agoni. The network helps show where Clement Agoni may publish in the future.

Co-authorship network of co-authors of Clement Agoni

This figure shows the co-authorship network connecting the top 25 collaborators of Clement Agoni. A scholar is included among the top collaborators of Clement Agoni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clement Agoni. Clement Agoni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agoni, Clement, et al.. (2025). Molecular Modelling in Bioactive Peptide Discovery and Characterisation. Biomolecules. 15(4). 524–524. 5 indexed citations
2.
Agoni, Clement, et al.. (2023). Computational Screening of Neuropilin‐1 Unveils Novel Potential Anti‐SARS‐CoV‐2 Therapeutics. Chemistry & Biodiversity. 20(12). e202301227–e202301227. 2 indexed citations
3.
Issahaku, Abdul Rashid, et al.. (2023). In silico identification of potential PvFKBP35 inhibitors from Entadrophragma angolense Limonoids extracts as antimalarial agents. Informatics in Medicine Unlocked. 41. 101319–101319. 7 indexed citations
4.
Agoni, Clement, et al.. (2023). Cell-Penetrating Milk-Derived Peptides with a Non-Inflammatory Profile. Molecules. 28(19). 6999–6999. 2 indexed citations
5.
Issahaku, Abdul Rashid, Clement Agoni, Mohammed Issa Alahmdi, et al.. (2023). Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach. ChemistrySelect. 8(24). 33 indexed citations
6.
Abo‐Dya, Nader E., Abdul Rashid Issahaku, Clement Agoni, et al.. (2022). Novel Sunifiram-carbamate hybrids as potential dual acetylcholinesterase inhibitor and NMDAR co-agonist: simulation-guided analogue design and pharmacological screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1241–1256. 6 indexed citations
7.
Shields, Denis C., et al.. (2022). Modelling the Transitioning of SARS-CoV-2 nsp3 and nsp4 Lumenal Regions towards a More Stable State on Complex Formation. International Journal of Molecular Sciences. 24(1). 720–720. 8 indexed citations
8.
Issahaku, Abdul Rashid, et al.. (2022). Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy. Scientific Reports. 12(1). 17796–17796. 59 indexed citations
9.
Rudrapal, Mithun, Abdul Rashid Issahaku, Clement Agoni, et al.. (2021). In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 40(20). 10437–10453. 61 indexed citations
10.
Mathew, Bijo, Jong‐Min Oh, Ahmed Khames, et al.. (2021). Replacement of Chalcone-Ethers with Chalcone-Thioethers as Potent and Highly Selective Monoamine Oxidase-B Inhibitors and Their Protein-Ligand Interactions. Pharmaceuticals. 14(11). 1148–1148. 10 indexed citations
11.
12.
Agoni, Clement, et al.. (2020). Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity—A Structural, Dynamical and Mechanistic Stance. Cell Biochemistry and Biophysics. 79(1). 11–24. 2 indexed citations
13.
Olotu, Fisayo A., et al.. (2020). An Update on the Pharmacological Usage of Curcumin: Has it Failed in the Drug Discovery Pipeline?. Cell Biochemistry and Biophysics. 78(3). 267–289. 32 indexed citations
14.
Agoni, Clement, et al.. (2020). Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches. South African Journal of Botany. 133. 273–284. 32 indexed citations
15.
16.
Agoni, Clement, et al.. (2020). Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives. Computational Biology and Chemistry. 85. 107204–107204. 7 indexed citations
17.
Agoni, Clement, et al.. (2020). ‘Polymorphism-aided’ Selective Targeting and Inhibition of Caspase-6 by a Novel Allosteric Inhibitor Towards Efficient Alzheimer’s Disease Treatment. Cell Biochemistry and Biophysics. 78(3). 291–299. 1 indexed citations
18.
Agoni, Clement, et al.. (2019). Learning the Footprints and Fingerprints: Pharmacophore Modeling in the Discovery of Potential Drug Candidates. 2(1). 1–9. 1 indexed citations
19.
Agoni, Clement, et al.. (2019). Human Rhinovirus Inhibition Through Capsid “Canyon” Perturbation: Structural Insights into The Role of a Novel Benzothiophene Derivative. Cell Biochemistry and Biophysics. 78(1). 3–13. 11 indexed citations
20.
Agoni, Clement, et al.. (2018). Microbes, not humans: exploring the molecular basis of Pseudouridimycin selectivity towards bacterial and not human RNA polymerase. Biotechnology Letters. 41(1). 115–128. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fisayo A. Olotu Breakdown of academic impact, for papers by Ramakrishna Vadde Breakdown of academic impact, for papers by Thales Kronenberger Breakdown of academic impact, for papers by Bilal Shaker Breakdown of academic impact, for papers by Shailima Rampogu Breakdown of academic impact, for papers by Umashankar Vetrivel Breakdown of academic impact, for papers by Stephani Joy Y. Macalino Breakdown of academic impact, for papers by Katrin Stierand Breakdown of academic impact, for papers by Prem Prakash Kushwaha Breakdown of academic impact, for papers by Shama Khan
Rankless by CCL
2026